Large-scale expansion of pre-isolated bone marrow mesenchymal stromal cells in serum-free conditions

Journal of Tissue Engineering and Regenerative Medicine

Volumn 10, Issue 2, 2016, Pages 108-119

  Gottipamula, Sanjay ^a   Muttigi, Manjunatha S ^a   Chaansa, S ^a   Ashwin, K M ^a   Priya, Nancy ^b   Kolkundkar, Udaykumar ^b   Sundar Raj, Swathi ^b   Majumdar, Anish Sen ^b   Seetharam, Raviraja N ^a  

^a Ecron Acunova   (India)

^b Stempeutics Research Pvt Limited   (India)

Author keywords

Bone marrow; Differentiation; Large scale expansion; Mesenchymal stromal cells; Phenotypic characterization; Serum free cultures

Indexed keywords

BODY FLUIDS; BONE; CELL CULTURE; DIAGNOSIS; EXPANSION; MAMMALS; STEM CELLS;

BONE MARROW; DIFFERENTIATION; LARGE-SCALE EXPANSION; LARGE-SCALES; MESENCHYMAL STEM CELL; MESENCHYMAL STROMAL CELLS; PHENOTYPIC CHARACTERIZATION; SERUM FREE; SERUM-FREE CULTURE; SERUM-FREE MEDIA;

FLOWCHARTING;

ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL EXPANSION; CELL GROWTH; CELL ISOLATION; CELL PROLIFERATION; HUMAN; HUMAN CELL; NORMAL HUMAN; PHENOTYPE; POPULATION DOUBLING TIME; PRIORITY JOURNAL; PROCEDURES CONCERNING CELLS; SERUM FREE MEDIA; BIOASSAY; BONE MARROW CELL; CELL SEPARATION; CELL SHAPE; CFU COUNTING; CYTOLOGY; IMMUNOMODULATION; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; KINETICS; MESENCHYMAL STROMA CELL; METABOLISM; PROCEDURES; SERUM-FREE MEDIUM; YOUNG ADULT;

BOVINE SERUM ALBUMIN; SERUM-FREE MEDIUM;

BIOLOGICAL ASSAY; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; CELL SHAPE; COLONY-FORMING UNITS ASSAY; CULTURE MEDIA, SERUM-FREE; HUMANS; IMMUNOMODULATION; IMMUNOPHENOTYPING; IMMUNOSUPPRESSION; KINETICS; MESENCHYMAL STROMAL CELLS; SERUM ALBUMIN, BOVINE; YOUNG ADULT;

EID: 84957844397     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1713     Document Type: Article

References (35)

1. + cells. Transfusion 42: 1573-1580.
2. Bernardo ME, Cometa AM, Pagliara D, et al. 2011; Ex vivo expansion of mesenchymal stromal cells. Best Pract Res Clin Haematol 24: 73-81.
3. Chase LG, Lakshmipathy U, Solchaga LA, et al. 2010; A novel serum-free medium for the expansion of human mesenchymal stem cells. Stem Cell Res Ther 1: 8.
4. Colter DC, Class R, Prockop DJ. 2000; Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci USA 97: 3213-3218.
5. Dimarakis I, Levicar N. 2006; Cell culture medium composition and translational adult bone marrow-derived stem cell research. Stem Cells 24(5): 1407-1408.
6. Dominici M, Le Blanc K, Mueller I, et al. 2006; Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317.
7. Doucet C, Ernou I, Zhang Y, et al. 2005; Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J Cell Physiol 205: 228-236.
8. Erickson GA, Bolin SR, Landgraf JG. 1991; Viral contamination of fetal bovine serum used for tissue culture: risks and concerns. Dev Biol Stand 75: 173-175.
9. Fouillard L, Chapel A, Bories D, et al. 2007; Infusion of allogeneic-related HLA mismatched mesenchymal stem cells for the treatment of incomplete engraftment following autologous haematopoietic stem cell transplantation. Leukemia 21: 568-570.
10. Gottipamula S, Sharma A, Krishnamurthy S, et al. 2012; Human platelet lysate is an alternative to fetal bovine serum for large-scale expansion of bone marrow-derived mesenchymal stromal cells. Biotechnol Lett 34: 1367-1374.
11. Hartmann I, Hollweck T, Haffner S, et al. 2010; Umbilical cord tissue-derived mesenchymal stem cells grow best under GMP-compliant culture conditions and maintain their phenotypic and functional properties. J Immunol Methods 363: 80-89.
12. Heiskanen A, Satomaa T, Tiitinen S, et al. 2007; N-glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible. Stem Cells 25(1): 197-202.
13. Hudson JE, Mills RJ, Frith JE, et al. 2011; A defined medium and substrate for expansion of human mesenchymal stromal cell progenitors that enriches for osteo- and chondrogenic precursors. Stem Cells Dev 20: 77-87.
14. Jung J, Moon N, Ahn JY, et al. 2009; Mesenchymal stromal cells expanded in human allogenic cord blood serum display higher self-renewal and enhanced osteogenic potential. Stem Cells Dev 18: 559-571.
15. Jung S, Panchalingam KM, Rosenberg L, et al. 2012; Ex vivo expansion of human mesenchymal stem cells in defined serum-free media. Stem Cells Int 2012: 123030.
16. Kotobuki N, Hirose M, Takakura Y, et al. 2004; Cultured autologous human cells for hard tissue regeneration: preparation and characterization of mesenchymal stem cells from bone marrow. Artif Organs 28: 33-39.
17. Lee MW, Yang MS, Park JS, et al. 2005; Isolation of mesenchymal stem cells from cryopreserved human umbilical cord blood. Int J Hematol 81: 126-130.
18. Marmont AM, Gualandi F, Piaggio G, et al. 2006; Allogeneic bone marrow transplantation (BMT) for refractory Behcet's disease with severe CNS involvement. Bone Marrow Transpl 37: 1061-1063.
19. Mimura S, Kimura N, Hirata M, et al. 2011; Growth factor-defined culture medium for human mesenchymal stem cells. Int J Dev Biol 55: 181-187.
20. Muller I, Kordowich S, Holzwarth C, et al. 2006; Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. Cytotherapy 8: 437-444.
21. Neuhuber B, Swanger SA, Howard L, et al. 2008; Effects of plating density and culture time on bone marrow stromal cell characteristics. Exp Hematol 36: 1176-1185.
22. Pal R, Hanwate M, Jan M, et al. 2009; Phenotypic and functional comparison of optimum culture conditions for upscaling of bone marrow-derived mesenchymal stem cells. J Tissue Eng Regen Med 3: 163-174.
23. Parker AM, Shang H, Khurgel M, et al. 2007; Low-serum and serum-free culture of multipotential human adipose stem cells. Cytotherapy 9: 637-646.
24. Pittenger MF, Mackay AM, Beck SC, et al. 1999; Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
25. Prockop DJ. 2007; 'Stemness' does not explain the repair of many tissues by mesenchymal stem/multipotent stromal cells (MSCs). Clin Pharmacol Ther 82: 241-243.
26. Salem HK, Thiemermann C. 2010; Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 28(3): 585-596.
27. Samson D, Slaper-Cortenbach I, Pamphilon D, et al. 2007; Current status of JACIE accreditation in Europe: a special report from the Joint Accreditation Committee of the ISCT and the EBMT (JACIE). Bone Marrow Transpl 39: 133-141.
28. Sekiya I, Larson BL, Smith JR, et al. 2002; Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 20: 530-541.
29. Sensebe L. 2008; Clinical grade production of mesenchymal stem cells. Biomed Mater Eng 18: S3-10.
30. Sensebe L, Bourin P, Tarte K. 2011; Good Manufacturing Practice production of mesenchymal stem/stromal cells. Hum Gene Ther 22: 19-26.
31. Shahdadfar A, Fronsdal K, Haug T, et al. 2005. In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. Stem Cells 23: 1357-1366.
32. Sotiropoulou PA, Perez SA, Salagianni M, et al. 2006; Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells 24: 462-471.
33. Spitkovsky D, Hescheler J. 2008; Adult mesenchymal stromal stem cells for therapeutic applications. Minim Invasive Ther Allied Technol 17: 79-90.
34. Tekkatte C, Gunasingh GP, Cherian KM, et al. 2011; Humanized stem cell culture techniques: the animal serum controversy. Stem Cells Int 2011: 504723.
35. Zuk PA, Zhu M, Ashjian P, et al. 2002. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13: 4279-4295.